Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
6 active Medicare policies list D59.39, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Jan 22, 2023
JM · Effective Jan 22, 2023
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
2 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D59.39 |
|---|---|---|
| ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP) | Oct 26, 2023 | Covered |
| Policy | Effective | Status of D59.39 |
|---|---|---|
| Therapeutic Apheresis | Apr 15, 2026 | Covered |